메뉴 건너뛰기




Volumn 23, Issue 4, 2005, Pages 1127-1139

Management of atrial fibrillation in the emergency department

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; ESMOLOL; METOPROLOL; PROCAINAMIDE; PROPRANOLOL; VERAPAMIL; WARFARIN;

EID: 26044466519     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2005.07.013     Document Type: Review
Times cited : (27)

References (37)
  • 1
    • 0031085292 scopus 로고    scopus 로고
    • Management of supraventricular tachycardia in the emergency department
    • S. Connors, and P. Dorian Management of supraventricular tachycardia in the emergency department Can J Cardiol 13 Suppl A 1997 19A 24A
    • (1997) Can J Cardiol , vol.13 , Issue.SUPPL. A
    • Connors, S.1    Dorian, P.2
  • 2
    • 0032722353 scopus 로고    scopus 로고
    • Epidemiology and significance of atrial fibrillation
    • K.M. Ryder, and E.J. Benjamin Epidemiology and significance of atrial fibrillation Am J Cardiol 84 9A 1999 131R 138R
    • (1999) Am J Cardiol , vol.84 , Issue.9 A
    • Ryder, K.M.1    Benjamin, E.J.2
  • 3
    • 0032497292 scopus 로고    scopus 로고
    • Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
    • E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 10 1998 946 952
    • (1998) Circulation , vol.98 , Issue.10 , pp. 946-952
    • Benjamin, E.J.1    Wolf, P.A.2    D'Agostino, R.B.3
  • 4
    • 0037050001 scopus 로고    scopus 로고
    • New ideas about atrial fibrillation 50 years on
    • S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 6868 2002 219 226 [review]
    • (2002) Nature , vol.415 , Issue.6868 , pp. 219-226
    • Nattel, S.1
  • 5
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized control trials
    • Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized control trials Arch Intern Med 154 1994 1449 1457
    • (1994) Arch Intern Med , vol.154 , pp. 1449-1457
    • Fibrillation Investigators, A.1
  • 6
    • 0028274016 scopus 로고
    • Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter: Insights into mechanisms
    • J. Ortiz, S. Niwano, and H. Abe Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter: insights into mechanisms Circ Res 74 5 1994 882 894
    • (1994) Circ Res , vol.74 , Issue.5 , pp. 882-894
    • Ortiz, J.1    Niwano, S.2    Abe, H.3
  • 7
    • 0002848836 scopus 로고
    • Tachycardia-induced tachycardia: A mechanism of initiation of atrial fibrillation
    • J.P. DiMarco E.N. Prystowsky Furtura Publishing Co Armonk (NY)
    • E.N. Prystowsky Tachycardia-induced tachycardia: a mechanism of initiation of atrial fibrillation J.P. DiMarco E.N. Prystowsky Atrial arrhythmias: state of the art 1995 Furtura Publishing Co Armonk (NY) 81 95
    • (1995) Atrial Arrhythmias: State of the Art , pp. 81-95
    • Prystowsky, E.N.1
  • 8
    • 0020964823 scopus 로고
    • Coronary heart disease and atrial fibrillation: The Framingham Study
    • W.B. Kannel, R.D. Abbott, and D.D. Savage Coronary heart disease and atrial fibrillation: the Framingham Study Am Heart J 106 2 1983 389 396
    • (1983) Am Heart J , vol.106 , Issue.2 , pp. 389-396
    • Kannel, W.B.1    Abbott, R.D.2    Savage, D.D.3
  • 9
    • 0035940379 scopus 로고    scopus 로고
    • ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation)
    • developed in collaboration with the North American Society of Pacing and Electrophysiology
    • V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Circulation 104 17 2001 2118 2150
    • (2001) Circulation , vol.104 , Issue.17 , pp. 2118-2150
    • Fuster, V.1    Ryden, L.E.2    Asinger, R.W.3
  • 10
    • 0032033096 scopus 로고    scopus 로고
    • Treatment strategies for atrial fibrillation
    • F. Jung, and J.P. DiMarco Treatment strategies for atrial fibrillation Am J Med 104 3 1998 272 286
    • (1998) Am J Med , vol.104 , Issue.3 , pp. 272-286
    • Jung, F.1    Dimarco, J.P.2
  • 11
    • 0037418332 scopus 로고    scopus 로고
    • Aymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide
    • R. Page, T.W. Tilsch, and S.J. Connolly Aymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141 1145
    • (2003) Circulation , vol.107 , pp. 1141-1145
    • Page, R.1    Tilsch, T.W.2    Connolly, S.J.3
  • 12
    • 0020613724 scopus 로고
    • Duration of atrial fibrillation and imminence of stroke: The Framingham study
    • P.A. Wolf, W.B. Kannel, and D.L. McGee Duration of atrial fibrillation and imminence of stroke: the Framingham study Stroke 14 5 1983 664 667
    • (1983) Stroke , vol.14 , Issue.5 , pp. 664-667
    • Wolf, P.A.1    Kannel, W.B.2    McGee, D.L.3
  • 13
    • 0036201197 scopus 로고    scopus 로고
    • Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome
    • T. Hamada, T. Hiraki, and H. Ikeda Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome J Cardiovasc Electrophysiol 13 3 2002 223 229
    • (2002) J Cardiovasc Electrophysiol , vol.13 , Issue.3 , pp. 223-229
    • Hamada, T.1    Hiraki, T.2    Ikeda, H.3
  • 14
    • 0035837496 scopus 로고    scopus 로고
    • Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
    • for the Assessment Of Cardioversion Using Transesophageal Echocardiography Investigators R.D.
    • A.L. Klein, R.A. Grimm, R.D. Murray for the Assessment Of Cardioversion Using Transesophageal Echocardiography Investigators Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 19 2001 1411 1420
    • (2001) N Engl J Med , vol.344 , Issue.19 , pp. 1411-1420
    • Klein, A.L.1    Grimm, R.A.2    Murray3
  • 15
    • 0034702737 scopus 로고    scopus 로고
    • Part 6: Advanced cardiovascular life support: Section 7: Algorithm approach to ACLS emergencies: 7C: a guide to the international ACLS algorithms
    • American Heart Association Part 6: Advanced cardiovascular life support: section 7: algorithm approach to ACLS emergencies: 7C: a guide to the international ACLS algorithms Circulation 102 Suppl I 2000 S158 S165
    • (2000) Circulation , vol.102 , Issue.SUPPL. I
    • Heart Association, A.1
  • 16
    • 0030848290 scopus 로고    scopus 로고
    • Dilemmas in the acute pharmacologic treatment of uncontrolled atrial fibrillation
    • K. Elam, and K.L. Bolar-Softich Dilemmas in the acute pharmacologic treatment of uncontrolled atrial fibrillation Am J Emerg Med 15 4 1997 418 419
    • (1997) Am J Emerg Med , vol.15 , Issue.4 , pp. 418-419
    • Elam, K.1    Bolar-Softich, K.L.2
  • 17
    • 0028969407 scopus 로고
    • Clinical rationale for the use of an ultra-short acting beta-blocker: Esmolol
    • G.H. Barbier, U.R. Shettigar, and D.O. Appunn Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol Int J Clin Pharmacol Ther 33 4 1995 212 218
    • (1995) Int J Clin Pharmacol Ther , vol.33 , Issue.4 , pp. 212-218
    • Barbier, G.H.1    Shettigar, U.R.2    Appunn, D.O.3
  • 18
    • 0034968891 scopus 로고    scopus 로고
    • VERDICT: The Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation
    • T. Van Noord, I.C. Van Gelder, and R.G. Tieleman VERDICT: the Verapamil versus Digoxin Cardioversion Trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation J Cardiovasc Electrophysiol 12 7 2001 766 769
    • (2001) J Cardiovasc Electrophysiol , vol.12 , Issue.7 , pp. 766-769
    • Van Noord, T.1    Van Gelder, I.C.2    Tieleman, R.G.3
  • 19
    • 0037028033 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
    • for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group H.A.
    • I.C. Van Gelder, V.E. Hagens, H.A. Bosker for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 23 2002 1834 1840
    • (2002) N Engl J Med , vol.347 , Issue.23 , pp. 1834-1840
    • Van Gelder, I.C.1    Hagens, V.E.2    Bosker3
  • 20
    • 0037028022 scopus 로고    scopus 로고
    • A comparison of rate control and rhythm control in patients with atrial fibrillation
    • for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators J.P.
    • D.G. Wyse, A.L. Waldo, J.P. DiMarco for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 23 2002 1825 1833
    • (2002) N Engl J Med , vol.347 , Issue.23 , pp. 1825-1833
    • Wyse, D.G.1    Waldo, A.L.2    Dimarco3
  • 21
    • 7244262597 scopus 로고    scopus 로고
    • Cost-effectiveness of rhythm versus rate control in atrial fibrillation
    • D. Marshall, A.R. Levy, and H. Vidaillet Cost-effectiveness of rhythm versus rate control in atrial fibrillation Ann Intern Med 141 2004 653 660
    • (2004) Ann Intern Med , vol.141 , pp. 653-660
    • Marshall, D.1    Levy, A.R.2    Vidaillet, H.3
  • 22
    • 0036200977 scopus 로고    scopus 로고
    • Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation
    • S.P. Fynn, D.M. Todd, and W.J. Hobbs Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation J Cardiovasc Electrophysiol 13 2 2002 135 141
    • (2002) J Cardiovasc Electrophysiol , vol.13 , Issue.2 , pp. 135-141
    • Fynn, S.P.1    Todd, D.M.2    Hobbs, W.J.3
  • 23
    • 0036798858 scopus 로고    scopus 로고
    • Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm: A randomized study
    • E. Bertaglia, D. D'Este, and F. Zerbo Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm: a randomized study Eur Heart J 23 19 2002 1522 1528
    • (2002) Eur Heart J , vol.23 , Issue.19 , pp. 1522-1528
    • Bertaglia, E.1    D'Este, D.2    Zerbo, F.3
  • 24
    • 17944390762 scopus 로고    scopus 로고
    • Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm
    • P.G. Danias, T.A. Caulfield, and M.J. Weigner Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm J Am Coll Cardiol 31 3 1998 588 592
    • (1998) J Am Coll Cardiol , vol.31 , Issue.3 , pp. 588-592
    • Danias, P.G.1    Caulfield, T.A.2    Weigner, M.J.3
  • 25
    • 26044454778 scopus 로고    scopus 로고
    • A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation
    • W.W. Decker, D.G. Goyal, and E.T. Boie A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation Acad Emerg Med 10 5 2003 543 544 [abstract: 358]
    • (2003) Acad Emerg Med , vol.10 , Issue.5 , pp. 543-544
    • Decker, W.W.1    Goyal, D.G.2    Boie, E.T.3
  • 26
    • 0026649118 scopus 로고
    • Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
    • for the Stroke Prevention in Atrial Fibrillation Investigators R.
    • G.C. Flaker, J.L. Blackshear, R. McBride for the Stroke Prevention in Atrial Fibrillation Investigators Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation J Am Coll Cardiol 20 3 1992 527 532
    • (1992) J Am Coll Cardiol , vol.20 , Issue.3 , pp. 527-532
    • Flaker, G.C.1    Blackshear, J.L.2    McBride3
  • 27
    • 0032896858 scopus 로고    scopus 로고
    • Cardioversion of paroxysmal atrial fibrillation in the emergency department
    • J.A. Michael, I.G. Stiell, and S. Agarwal Cardioversion of paroxysmal atrial fibrillation in the emergency department Ann Emerg Med 33 4 1999 379 387
    • (1999) Ann Emerg Med , vol.33 , Issue.4 , pp. 379-387
    • Michael, J.A.1    Stiell, I.G.2    Agarwal, S.3
  • 28
    • 0037134946 scopus 로고    scopus 로고
    • Biphasic versus monophasic shock waveform for conversion of atrial fibrillation
    • R.L. Page, R.E. Kerber, and J.K. Russell Biphasic versus monophasic shock waveform for conversion of atrial fibrillation JACC 39 12 2002 1956 1963
    • (2002) JACC , vol.39 , Issue.12 , pp. 1956-1963
    • Page, R.L.1    Kerber, R.E.2    Russell, J.K.3
  • 29
    • 0036667623 scopus 로고    scopus 로고
    • How to enhance acute outcome of electrical cardioversion by drug therapy: Importance of immediate reinitiation of atrial fibrillation
    • T. Van Noord, I.C. Van Gelder, and H.J. Crijns How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation J Cardiovasc Electrophysiol 13 8 2002 822 825
    • (2002) J Cardiovasc Electrophysiol , vol.13 , Issue.8 , pp. 822-825
    • Van Noord, T.1    Van Gelder, I.C.2    Crijns, H.J.3
  • 30
    • 0029008638 scopus 로고
    • Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
    • M.F. Stoddard, P.R. Dawkins, and C.R. Prince Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation Am Heart J 129 6 1995 1204 1215
    • (1995) Am Heart J , vol.129 , Issue.6 , pp. 1204-1215
    • Stoddard, M.F.1    Dawkins, P.R.2    Prince, C.R.3
  • 31
    • 0030978128 scopus 로고    scopus 로고
    • Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours
    • M.J. Weigner, T.A. Caulfield, and P.G. Danias Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours Ann Intern Med 126 8 1997 615 620
    • (1997) Ann Intern Med , vol.126 , Issue.8 , pp. 615-620
    • Weigner, M.J.1    Caulfield, T.A.2    Danias, P.G.3
  • 32
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • A.S. Go, E.M. Hylek, and Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 20 2003 2685 2692
    • (2003) JAMA , vol.290 , Issue.20 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3
  • 33
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 22 2001 2864 2870
    • (2001) JAMA , vol.285 , Issue.22 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 34
    • 0025856242 scopus 로고
    • The surgical treatment of atrial fibrillation: II: intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation
    • J.L. Cox, T.E. Canavan, and R.B. Schuessler The surgical treatment of atrial fibrillation: II: intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation J Thorac Cardiovasc Surg 101 1991 406 426
    • (1991) J Thorac Cardiovasc Surg , vol.101 , pp. 406-426
    • Cox, J.L.1    Canavan, T.E.2    Schuessler, R.B.3
  • 35
    • 0001754854 scopus 로고
    • A catheter-based curative approach to atrial fibrillation in humans
    • J.F. Swartz, G. Pellersels, and J. Silvers A catheter-based curative approach to atrial fibrillation in humans Circulation 90 Suppl I 1994 I335 [abstract]
    • (1994) Circulation , vol.90 , Issue.SUPPL. I , pp. 335
    • Swartz, J.F.1    Pellersels, G.2    Silvers, J.3
  • 36
    • 0001376368 scopus 로고    scopus 로고
    • Right atrial radiofrequency catheter ablation of paroxysmal atrial fibrillation
    • K.C. Man, E. Daoud, and B. Knight Right atrial radiofrequency catheter ablation of paroxysmal atrial fibrillation J Am Coll Cardiol 27 Suppl A 1996 188A [abstract]
    • (1996) J Am Coll Cardiol , vol.27 , Issue.SUPPL. A
    • Man, K.C.1    Daoud, E.2    Knight, B.3
  • 37
    • 0028956957 scopus 로고
    • Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans
    • F.D. Murgatroyd, A.K.B. Slade, and S.M. Sopher Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans J Am Coll Cardiol 26 1995 1347 1353
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1347-1353
    • Murgatroyd, F.D.1    Slade, A.K.B.2    Sopher, S.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.